期刊文献+

COPD急性加重期并发CPHD心力衰竭患者血BNP和内脂素水平的临床意义 被引量:5

Significance of serum BNP and visfatin level in patients with acute exacerbation of chronic obstruction pulmonary disease complicated with chronic pulmonary heart disease and heart failure
下载PDF
导出
摘要 目的探讨慢性阻塞性肺病(COPD)急性加重期并发慢性肺源性心脏病(CPHD)心力衰竭时血B型脑钠肽(BNP)及内脂素变化的意义。方法选择COPD急性加重期并发CPHD心力衰竭患者75例,健康体检者50例,根据NYHA心功能分级方法对患者进行分组,检测及比较各组的BNP和内脂素及其与血氧分压(PaO_2)之间的关系。结果COPD急性加重期并发CPHD患者组BNP和内脂素水平显著高于健康体检者(P<0.05),随心功能分级增加BNP和内脂素水平而逐渐升高、PaO_2水平逐步下降,PaO_2与BNP和内脂素水平呈负相关(r=-0.381,-0.295,均P<0.05),BNP和内脂素呈正相关(r=0.361,P<0.05)。结论 COPD急性加重期并发CPHD心力衰竭患者BNP和内脂素水平明显升高,与缺氧有关。 Objective To investigate significance of serum BNP and visfatin level in patients with acute exacerbation of chronic obstruction pulmonary disease (COPD) complicated with chronic pulmonary heart disease (CPHD) and heart failure (HF). Methods 75 patients with acute exacerbation of COPD complicated with CPHD and HF and 50 healthy people were enrol ed. The patients were grouped according to New York Heart Association (NYHA) classification.Serum BNP and visfatin concentrations were measured and compared between groups and their relation to PaO2 was determined. Results The serum BNP and visfatin were significantly higher in the patients with acute exacerbation of COPD and CPHD than in healthy people (P〈0.05).The serum BNP and visfatin level increased and PaO2 decreased gradual y as NYHA class increased.PaO2 was negatively correlated with serum BNP and visfatin (r= - 0.381, - 0.295, P〈0.05).BNP was positively correlated with visfatin(r=0.361, P〈0.05). Conclusion Serum BNP and visfatin increase obviously in patients with acute exacerbation of COPD complicated with CPHD and HF, which are correlated with hypoxia.
出处 《心电与循环》 2015年第2期92-93,97,共3页 Journal of Electrocardiology and Circulation
关键词 慢性阻塞性肺病 慢性肺源性心脏病 B型脑钠肽 内脂素 Chronic obstruction pulmonary disease Chronic pulmonary heart disease BNP Visfatin
  • 相关文献

参考文献2

二级参考文献9

  • 1胡大一,杨振华.B型钠尿肤的临床应用和新进展[M].北京:北京科学技术出版社.2006:14-22.
  • 2Koiier KJ, Goeddel DV. Molecular biology of the natriuretic Peptides and their receptors[J].Clrculation, 1992,86(4): 1081-1088.
  • 3Ellis R, Levin MD, David G, et al. D. Natriuretie peptide [J]. N Engl J Med. 1998,339(30):321-328.
  • 4Robert. Hobbs, MD. Using BNP to diagnose, manage, and treat heart failure[J]. Clevel and Clinic Journal of Medicine,2003,70(4):333-336.
  • 5Richard W Troughton, Christopher M Frampton,Timothy G Yandle,et al. Treatment of heart failure guided by plasma aminoterminal brain natri- uretic peptide (N-BNP) concentrations[J].The Lancet,2000, 9210(355): 1126-1130.
  • 6陆再英,钟南山.内科学[M].北京:人民卫生出版社,2011:543-548.
  • 7Patil SP , Krishnan JA, Lechtzin N, et al. In hospital mortality fol- lowing acute exacerbations of COPD[ J]. Arch Intern Med, 2003, 163:1180 - 1186.
  • 8Groenewegen KH, Schols MW J , Wonters FM. Mortality and mor- tality-related factors after hospitalization for acute exacerbation of COPD[ J]. Chest, 2003,124:459 - 467.
  • 9阎锡新,徐海博,田茶,齐顺祥,韩彩芝,李素引,赵瑞珍,杨丛丽,刘菲菲,王瑜玲,韩晓文,平芬,蒋超英,金普乐.冬季慢性阻塞性肺疾病急性加重住院患者病原学与预后分析[J].中国实用内科杂志,2010,30(4):320-323. 被引量:6

共引文献75

同被引文献53

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部